JP2010520186A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010520186A5 JP2010520186A5 JP2009551256A JP2009551256A JP2010520186A5 JP 2010520186 A5 JP2010520186 A5 JP 2010520186A5 JP 2009551256 A JP2009551256 A JP 2009551256A JP 2009551256 A JP2009551256 A JP 2009551256A JP 2010520186 A5 JP2010520186 A5 JP 2010520186A5
- Authority
- JP
- Japan
- Prior art keywords
- buprenorphine
- naloxone
- composition
- patient
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims 10
- 229960001736 buprenorphine Drugs 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 7
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 claims 7
- 229960004127 naloxone Drugs 0.000 claims 7
- 230000037396 body weight Effects 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 230000000202 analgesic effect Effects 0.000 claims 1
- SFNLWIKOKQVFPB-KZCPYJDTSA-N bunavail Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C.C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 SFNLWIKOKQVFPB-KZCPYJDTSA-N 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0703968A GB2447016A (en) | 2007-03-01 | 2007-03-01 | Buprenorphine/naloxone compositions |
| PCT/GB2008/000526 WO2008104738A1 (en) | 2007-03-01 | 2008-02-15 | Improvements in and relating to medicinal compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014123827A Division JP2014196325A (ja) | 2007-03-01 | 2014-06-16 | 医薬組成物における改善および医薬組成物に関する改善 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010520186A JP2010520186A (ja) | 2010-06-10 |
| JP2010520186A5 true JP2010520186A5 (OSRAM) | 2011-03-31 |
Family
ID=37965735
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009551256A Pending JP2010520186A (ja) | 2007-03-01 | 2008-02-15 | 医薬組成物における改善および医薬組成物に関する改善 |
| JP2014123827A Abandoned JP2014196325A (ja) | 2007-03-01 | 2014-06-16 | 医薬組成物における改善および医薬組成物に関する改善 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014123827A Abandoned JP2014196325A (ja) | 2007-03-01 | 2014-06-16 | 医薬組成物における改善および医薬組成物に関する改善 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110046172A1 (OSRAM) |
| EP (1) | EP2129380A1 (OSRAM) |
| JP (2) | JP2010520186A (OSRAM) |
| KR (1) | KR20090117891A (OSRAM) |
| CN (1) | CN101626766B (OSRAM) |
| AR (1) | AR065579A1 (OSRAM) |
| AU (1) | AU2008220574A1 (OSRAM) |
| BR (1) | BRPI0807908A2 (OSRAM) |
| CA (1) | CA2678582A1 (OSRAM) |
| CL (1) | CL2008000606A1 (OSRAM) |
| GB (1) | GB2447016A (OSRAM) |
| MX (1) | MX2009009131A (OSRAM) |
| PE (1) | PE20090168A1 (OSRAM) |
| TW (1) | TWI451868B (OSRAM) |
| WO (1) | WO2008104738A1 (OSRAM) |
| ZA (1) | ZA200905664B (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
| US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
| US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
| US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
| US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| UA102128C2 (en) | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
| US8475832B2 (en) * | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
| US9277748B2 (en) * | 2010-03-12 | 2016-03-08 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Agonist/antagonist compositions and methods of use |
| US8529914B2 (en) * | 2010-06-28 | 2013-09-10 | Richard C. Fuisz | Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
| US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
| JP6158810B2 (ja) * | 2011-08-18 | 2017-07-05 | バイオデリバリー サイエンシズ インターナショナル，インコーポレーテッド | ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス |
| PT2706986E (pt) | 2011-09-19 | 2015-07-07 | Orexo Ab | Nova composição farmacêutica resistente ao abuso para o tratamento da dependência de opiáceos |
| KR20210003313A (ko) * | 2011-12-21 | 2021-01-11 | 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 | 만성 통증 완화에 이용되는 점막 관통 약물 전달 장치 |
| CN103690495B (zh) * | 2013-12-19 | 2015-04-08 | 贵州景峰注射剂有限公司 | 注射用盐酸纳洛酮的冷冻干燥方法 |
| US9480644B2 (en) | 2014-03-14 | 2016-11-01 | Opiant Pharmaceuticals, Inc. | Nasal drug products and methods of their use |
| RU2016136714A (ru) | 2014-03-14 | 2018-04-19 | ОПИАНТ ФАРМАСЮТИКАЛС, Инк. | Назальные готовые лекарственные формы и способы их применения |
| US10085937B2 (en) | 2014-03-14 | 2018-10-02 | Adapt Pharma Limited | Nasal drug products and methods of their use |
| US9561177B2 (en) | 2014-03-14 | 2017-02-07 | Adapt Pharma Limited | Nasal drug products and methods of their use |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| KR20230137362A (ko) | 2016-05-05 | 2023-10-04 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 조성물 |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8332556D0 (en) * | 1983-12-06 | 1984-01-11 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
| JPH1036265A (ja) * | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | ブプレノルフィン経皮吸収製剤 |
| AR031682A1 (es) * | 1999-11-19 | 2003-10-01 | Reckitt Benckiser Helthcare Uk | Composiciones farmaceuticas |
| US20050191340A1 (en) * | 2002-08-09 | 2005-09-01 | Gruenenthal Gmbh | Opioid-receptor antagonists in transdermal systems having buprenorphine |
| ES2290512T3 (es) * | 2002-08-09 | 2008-02-16 | Grunenthal Gmbh | Antagonistas del receptor opioide en sistemas transdermicos que contienen buprenorfina. |
-
2007
- 2007-03-01 GB GB0703968A patent/GB2447016A/en not_active Withdrawn
-
2008
- 2008-02-15 KR KR1020097018305A patent/KR20090117891A/ko not_active Ceased
- 2008-02-15 BR BRPI0807908-0A2A patent/BRPI0807908A2/pt not_active IP Right Cessation
- 2008-02-15 MX MX2009009131A patent/MX2009009131A/es not_active Application Discontinuation
- 2008-02-15 AU AU2008220574A patent/AU2008220574A1/en not_active Abandoned
- 2008-02-15 CA CA002678582A patent/CA2678582A1/en not_active Abandoned
- 2008-02-15 US US12/529,171 patent/US20110046172A1/en not_active Abandoned
- 2008-02-15 WO PCT/GB2008/000526 patent/WO2008104738A1/en not_active Ceased
- 2008-02-15 CN CN2008800068666A patent/CN101626766B/zh not_active Expired - Fee Related
- 2008-02-15 JP JP2009551256A patent/JP2010520186A/ja active Pending
- 2008-02-15 EP EP08709417A patent/EP2129380A1/en not_active Withdrawn
- 2008-02-27 TW TW097106779A patent/TWI451868B/zh not_active IP Right Cessation
- 2008-02-28 CL CL200800606A patent/CL2008000606A1/es unknown
- 2008-02-29 PE PE2008000413A patent/PE20090168A1/es not_active Application Discontinuation
- 2008-02-29 AR ARP080100880A patent/AR065579A1/es not_active Application Discontinuation
-
2009
- 2009-08-14 ZA ZA200905664A patent/ZA200905664B/xx unknown
-
2014
- 2014-06-16 JP JP2014123827A patent/JP2014196325A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010520186A5 (OSRAM) | ||
| JP2010520183A5 (OSRAM) | ||
| MX2009009131A (es) | Mejoras en y con relacion a composiciones medicinales. | |
| MX2009009132A (es) | Composiciones medicinales mejoradas que comprenden buprenorfina y naltrexona. | |
| JP2010520185A5 (OSRAM) | ||
| JP2010520184A5 (OSRAM) | ||
| CA2661759A1 (en) | Buprenophine-wafer for drug substitution therapy | |
| IL203747A (en) | Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it | |
| JP2003514013A5 (OSRAM) | ||
| JP2010535805A5 (OSRAM) | ||
| JP2009544619A5 (OSRAM) | ||
| JP2009280627A5 (OSRAM) | ||
| MX2009009133A (es) | Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona. | |
| RU2002116361A (ru) | Анальгезирующие композиции, содержащие бупренорфин | |
| MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
| WO2012007159A3 (en) | Novel gastro-retentive dosage forms | |
| JPWO2006016530A1 (ja) | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 | |
| WO2007098479A3 (en) | Localized insulin delivery for bone healing | |
| NZ613291A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| JP2010526837A5 (OSRAM) | ||
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| MX2009009134A (es) | Composiciones medicinales mejoradas que comprenden buprenorfina y nalmefeno. | |
| NZ595376A (en) | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | |
| CA3211907A1 (en) | New peptide conjugates | |
| JP2008534503A5 (OSRAM) |